| Performance Evaluation of Mpox Molecular POC Diagnostics (NCT07620600) | Foundation for Innovative New Diagnostics, Switzerland | 2026-06-15 |
| Non-invasive Malaria Diagnostic Data Collection in Ethiopia (NCT07456969) | Foundation for Innovative New Diagnostics, Switzerland | 2026-04-01 |
| Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study (NCT06019052) | Foundation for Innovative New Diagnostics, Switzerland | 2025-09-01 |
| Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection (NCT06213051) | Foundation for Innovative New Diagnostics, Switzerland | 2024-07-25 |
| Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya. (NCT05944731) | Foundation for Innovative New Diagnostics, Switzerland | 2024-02-05 |
| Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in South Africa (NCT05944718) | Foundation for Innovative New Diagnostics, Switzerland | 2023-09-11 |
| BGM and HbA1c POC Device Evaluation (NCT06170515) | Foundation for Innovative New Diagnostics, Switzerland | 2023-04-03 |
| COVID-19 Novel Molecular Point of Care Diagnostics Evaluation (NCT06055218) | Foundation for Innovative New Diagnostics, Switzerland | 2023-01-30 |
| Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya (NCT05386875) | Foundation for Innovative New Diagnostics, Switzerland | 2022-12-31 |
| Evaluation Study of DPP® Typhoid Assay (NCT05579821) | Foundation for Innovative New Diagnostics, Switzerland | 2022-09-15 |
| Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2) (NCT05405296) | Foundation for Innovative New Diagnostics, Switzerland | 2022-08-30 |
| TB-CAPT CORE Truenat Trial (NCT04568954) | Foundation for Innovative New Diagnostics, Switzerland | 2022-08-28 |
| Evaluation Study of Dengue RDTs (NCT05580731) | Foundation for Innovative New Diagnostics, Switzerland | 2022-07-31 |
| Evaluation of the Performance of Rapid Diagnostics for SARS-CoV-2 Self-testing in the Hands of Untrained (NCT05605769) | Foundation for Innovative New Diagnostics, Switzerland | 2022-07-13 |
| Abbott NxTekTM Malaria RDT WHO Prequalification Study (NCT05444790) | Foundation for Innovative New Diagnostics, Switzerland | 2022-06-30 |
| Novel Rapid POC Diagnostics for COVID-19 (NCT05438589) | Foundation for Innovative New Diagnostics, Switzerland | 2022-04-25 |
| Bioneer Q-RFIA Clinical Evaluation (NCT05117788) | Foundation for Innovative New Diagnostics, Switzerland | 2022-02-23 |
| Cardiometabolic Devices Accuracy Study (NCT05257564) | Foundation for Innovative New Diagnostics, Switzerland | 2022-02-14 |
| Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria (NCT03394976) | Foundation for Innovative New Diagnostics, Switzerland | 2022-01-31 |
| HCV Self-testing in Georgia (NCT04961723) | Foundation for Innovative New Diagnostics, Switzerland | 2021-12-10 |
| RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study (NCT05085301) | Foundation for Innovative New Diagnostics, Switzerland | 2021-12-01 |
| HCV Self-testing in Pakistan (NCT04971538) | Foundation for Innovative New Diagnostics, Switzerland | 2021-11-29 |
| HCV Self-testing in Malaysia (NCT04982718) | Foundation for Innovative New Diagnostics, Switzerland | 2021-09-14 |
| Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure (NCT05426577) | Foundation for Innovative New Diagnostics, Switzerland | 2021-09-01 |
| TB-CAPT MTB/XDR Study (NCT04567368) | Foundation for Innovative New Diagnostics, Switzerland | 2021-05-14 |
| Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal (NCT05050825) | Foundation for Innovative New Diagnostics, Switzerland | 2021-05-03 |
| Clinical Evaluation of tNGS for Diagnosis of DR-TB (NCT04239326) | Foundation for Innovative New Diagnostics, Switzerland | 2021-04-16 |
| Commercial Typhoid Tests Validation Trial (NCT04801602) | Foundation for Innovative New Diagnostics, Switzerland | 2020-10-25 |
| Innovation Platform (NCT04558528) | Foundation for Innovative New Diagnostics, Switzerland | 2020-10-01 |
| Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso (NCT04582474) | Foundation for Innovative New Diagnostics, Switzerland | 2020-09-10 |
| Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention (NCT04081051) | Foundation for Innovative New Diagnostics, Switzerland | 2020-08-31 |
| Automated Microscopy Evaluation Study (NCT04558515) | Foundation for Innovative New Diagnostics, Switzerland | 2020-02-01 |
| DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV (NCT04317729) | Foundation for Innovative New Diagnostics, Switzerland | 2020-01-30 |
| Truenat™ HCV RNA Assay Evaluation (NCT04236973) | Foundation for Innovative New Diagnostics, Switzerland | 2020-01-12 |
| FujiLAM Prospective Evaluation Trial (NCT04089423) | Foundation for Innovative New Diagnostics, Switzerland | 2019-12-13 |
| Evaluation of the DPP II Assay in Laos (NCT04299607) | Foundation for Innovative New Diagnostics, Switzerland | 2019-11-12 |
| Diagnostic Accuracy of the DPP II Assay (NCT04299412) | Foundation for Innovative New Diagnostics, Switzerland | 2019-10-28 |
| Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa (NCT03646981) | Foundation for Innovative New Diagnostics, Switzerland | 2019-09-01 |
| Evaluation Study of HCV RDTs in Fresh Samples (NCT04139941) | Foundation for Innovative New Diagnostics, Switzerland | 2019-07-31 |
| Xpert MTB/XDR Clinical Evaluation Trial (NCT03728725) | Foundation for Innovative New Diagnostics, Switzerland | 2019-07-11 |
| Stool Processing Kit (SPK) Evaluation for Pediatric Tuberculosis (TB) (NCT04899076) | Foundation for Innovative New Diagnostics, Switzerland | 2019-06-19 |
| Evaluation of Centralised TB Assay Solutions (NCT04147676) | Foundation for Innovative New Diagnostics, Switzerland | 2019-05-20 |
| Clinical Evaluation of the STANDARD™ Q Malaria/CRP Duo Test (NCT04791800) | Foundation for Innovative New Diagnostics, Switzerland | 2019-04-08 |
| Evaluation of Dried Blood Spot for HCV RNA Testing (NCT03896087) | Foundation for Innovative New Diagnostics, Switzerland | 2019-04-01 |
| Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test (NCT03712709) | Foundation for Innovative New Diagnostics, Switzerland | 2019-03-12 |
| Evaluation Study of RDTs Detecting Antibodies Against HCV (NCT04033887) | Foundation for Innovative New Diagnostics, Switzerland | 2018-09-21 |
| Actionable Results: Bloodstream Infection Molecular Assay Evaluation (NCT03255759) | Foundation for Innovative New Diagnostics, Switzerland | 2018-05-24 |
| Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia (NCT03594838) | Foundation for Innovative New Diagnostics, Switzerland | 2018-05-21 |
| Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea (NCT03462615) | Foundation for Innovative New Diagnostics, Switzerland | 2018-04-01 |